Howe & Rusling Inc Sarepta Therapeutics, Inc. Transaction History

Howe & Rusling Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $9,340 - $13,177	149 New	149 $11,000
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $823 - $1,316	-10 Closed	0 $0
Q3 2019 Oct 31, 2019	SELL	$72.81 - $156.91 $509 - $1,098	-7 Reduced 41.18%	10 $1,000
Q1 2019 Apr 29, 2019	SELL	$106.67 - $151.68 $2,133 - $3,033	-20 Reduced 54.05%	17 $2,000
Q1 2018 May 14, 2018	BUY	$54.02 - $82.27 $918 - $1,398	17 Added 85.0%	37 $3,000
Q4 2017 Jan 24, 2018	BUY	$47.64 - $56.75 $952 - $1,135	20	20 $1,000

528

83.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.